Levosalbutamol + Budesonide in pharma franchise in Rajasthan

Levosalbutamol + Budesonide in PCD pharma franchise in Kolkata

Levosalbutamol + Budesonide in top pharma company in Nagaon

Levosalbutamol + Budesonide in pcd pharma supplier in Bhubaneswar

Levosalbutamol + Budesonide in phama franchise company in India
Levosalbutamol + Budesonide in phama distributor in Patna

Home/Products /levosalbutamol-1-point-25mg-budesonide-0-point-5mg-respule

Buditerm L Respule

Composition : Levosalbutamol (1.25mg) + Budesonide (0.5mg) Respule

Dosage Form : Respule

Packaging Type : Sachets

Packaging : 4*5*2ml

Price : ₹300/-

Buditerm L Respule is a combination of Levosalbutamol (1.25mg) and Budesonide (0.5mg) designed for use in the treatment and management of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. Levosalbutamol, a selective beta-2 agonist, acts as a bronchodilator, helping to relax the muscles in the airways and improve airflow. Budesonide, a corticosteroid, reduces inflammation and swelling in the airways, helping to prevent asthma attacks and COPD flare-ups.

This dual-action formulation provides both immediate relief from bronchoconstriction (due to Levosalbutamol) and long-term control by reducing airway inflammation (due to Budesonide). It is typically administered through a nebulizer, delivering the active ingredients directly to the lungs for maximum efficacy. Buditerm L Respule is used for both the acute relief of bronchospasm and as a maintenance therapy to prevent symptoms and reduce the frequency of flare-ups.

It is particularly effective for patients with moderate to severe asthma or COPD who need a combination of a bronchodilator and anti-inflammatory treatment to manage their condition. This medication helps control asthma symptoms such as wheezing, shortness of breath, and tightness in the chest, as well as reduce the frequency of exacerbations.

Read More

About the Product

Buditerm L Respule is a combination of Levosalbutamol (1.25mg) and Budesonide (0.5mg) designed for use in the treatment and management of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. Levosalbutamol, a selective beta-2 agonist, acts as a bronchodilator, helping to relax the muscles in the airways and improve airflow. Budesonide, a corticosteroid, reduces inflammation and swelling in the airways, helping to prevent asthma attacks and COPD flare-ups.

This dual-action formulation provides both immediate relief from bronchoconstriction (due to Levosalbutamol) and long-term control by reducing airway inflammation (due to Budesonide). It is typically administered through a nebulizer, delivering the active ingredients directly to the lungs for maximum efficacy. Buditerm L Respule is used for both the acute relief of bronchospasm and as a maintenance therapy to prevent symptoms and reduce the frequency of flare-ups.

It is particularly effective for patients with moderate to severe asthma or COPD who need a combination of a bronchodilator and anti-inflammatory treatment to manage their condition. This medication helps control asthma symptoms such as wheezing, shortness of breath, and tightness in the chest, as well as reduce the frequency of exacerbations.

Possible side effects include throat irritation, hoarseness, dry mouth, headache, and a cough. In rare cases, tremors or palpitations may occur.

Indicated for the treatment of asthma and COPD, helping to relieve bronchospasm and reduce airway inflammation.

Consult your doctor if you have a history of cardiovascular diseases, infections, or tuberculosis before use.

Store in a cool, dry place away from direct sunlight and moisture. Keep out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation